Clincosm LogoSign in Get a demo

leptomeningeal metastasis

Showing 1 - 25 of 28
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Brain Cancer, Glioblastoma, Metastatic Cancer Trial in New York (Trastuzumab deruxtecan)

Recruiting
  • Brain Cancer
  • +4 more
  • Trastuzumab deruxtecan
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Sep 22, 2023

NSCLC, Epidermal Growth Factor Receptor, Leptomeningeal Metastasis Trial (Pemetrexed)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +2 more
  • (no location specified)
Mar 27, 2023

Breast Cancer Metastatic, Leptomeningeal Metastasis Trial (Tucatinib Oral Tablet, Capecitabine tablets, Trastuzumab Injection)

Not yet recruiting
  • Breast Cancer Metastatic
  • Leptomeningeal Metastasis
  • Tucatinib Oral Tablet
  • +2 more
  • (no location specified)
Mar 23, 2023

Leptomeningeal Metastasis Trial in Aarhus (CSI)

Not yet recruiting
  • Leptomeningeal Metastasis
  • CSI
  • Aarhus, Denmark
    Aarhus University Hospital
Feb 28, 2023

Brain Metastases, Leptomeningeal Metastasis Trial in United States (GDC-0084, whole brain radiation therapy radiation)

Recruiting
  • Brain Metastases
  • Leptomeningeal Metastasis
  • GDC-0084
  • whole brain radiation therapy radiation
  • Miami, Florida
  • +9 more
Jan 3, 2023

HER2-positive Breast Cancer, Leptomeningeal Metastasis, Leptomeningeal Disease Trial in Tampa, Evanston (Radiation Therapy,

Recruiting
  • HER2-positive Breast Cancer
  • +2 more
  • Radiation Therapy
  • +2 more
  • Tampa, Florida
  • +1 more
Dec 30, 2022

Leptomeningeal Metastasis, NSCLC Stage IV, Melanoma Stage IV Trial in Geneva, St Gallen, Zurich (intrathecal nivolumab and

Recruiting
  • Leptomeningeal Metastasis
  • +2 more
  • intrathecal nivolumab and intrathecal ipilimumab
  • Geneva, Switzerland
  • +2 more
Dec 18, 2022

Patients With Leptomeningeal Metastases ((LM) Using CNSide

Recruiting
  • Leptomeningeal Metastasis
  • +4 more
  • CNSide
  • Los Angeles, California
    Valkyrie Clinical Trials
Sep 7, 2022

Leptomeningeal Metastasis, Solid Tumor, Adult Trial in United Kingdom, United States (radiolabeled DPTA-omburtamab)

Withdrawn
  • Leptomeningeal Metastasis
  • Solid Tumor, Adult
  • radiolabeled DPTA-omburtamab
  • Los Angeles, California
  • +7 more
Jul 12, 2022

Leptomeningeal Metastasis Trial in Dallas, San Antonio (186RNL)

Recruiting
  • Leptomeningeal Metastasis
  • Dallas, Texas
  • +1 more
Jul 12, 2022

Non Small Cell Lung Cancer Metastatic, Leptomeningeal Metastasis, Brain Metastases Trial in France (Osimertinib)

Recruiting
  • Non Small Cell Lung Cancer Metastatic
  • +3 more
  • Aix-en-Provence, France
  • +36 more
Jun 28, 2022

Leptomeningeal Metastasis Trial in Changchun (Pemetrexed, Radiotherapy)

Recruiting
  • Leptomeningeal Metastasis
  • Changchun, Jilin, China
    The First Hospital of Jilin University
Jun 8, 2022

Leptomeningeal Metastasis, Immune Checkpoint Inhibitor, Endostatin Trial in Hebei (Camrelizumab or envafolimab)

Recruiting
  • Leptomeningeal Metastasis
  • +2 more
  • Camrelizumab or envafolimab
  • Hebei, China
    The Second Hospital of Hebei Medical University
May 19, 2022

NSCLC, EGFR Activating Mutation, Brain Metastases Trial in Beijing (TY-9591 Tablets)

Recruiting
  • NSCLC
  • +3 more
  • TY-9591 Tablets
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospitial,Chinese Academy of Medic
May 14, 2022

Breast Cancer, Leptomeningeal Metastasis Trial in Lille (Cerebrospinal fluid and blood sample collection at the initial

Withdrawn
  • Breast Cancer
  • Leptomeningeal Metastasis
  • Cerebrospinal fluid and blood sample collection at the initial diagnostic assessment
  • +2 more
  • Lille, Hauts-de- France, France
  • +1 more
Oct 5, 2021

Solid Tumor, Solid Tumor, Adult, Leptomeningeal Metastasis Trial in Boston (Pembrolizumab, Lenvatinib)

Recruiting
  • Solid Tumor
  • +2 more
  • Boston, Massachusetts
  • +1 more
Sep 22, 2021

NSCLC, Brain Metastases, Leptomeningeal Metastasis Trial in Zhengzhou (almonertinib, LM-first line treatment, LM-second line

Recruiting
  • NSCLC
  • +2 more
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Aug 25, 2021

NSCLC, Leptomeningeal Metastasis, EGFR Activating Mutation Trial in Nanchang (Almonertinib, Bevacizumab)

Not yet recruiting
  • NSCLC
  • +2 more
  • Nanchang, Jiangxi, China
    The Second Afiliated Hospital of Nanchang University
Jun 26, 2021

Leptomeningeal Metastasis, Lung Cancer Trial in Hebei (Nimotuzumab)

Recruiting
  • Leptomeningeal Metastasis
  • Lung Cancer
  • Hebei, Shijiazhuang/hebei, China
  • +1 more
Apr 18, 2021

Circulating Tumor DNA in Cerebrospinal Fluid asEarly Biomarker

Completed
  • Leptomeningeal Metastasis
    • Lebanon, New Hampshire
      Dartmouth-Hitchcock Medical Center
    Aug 14, 2020

    Leptomeningeal Metastasis Trial (Recombinant Human Endostatin, intrathcal methotrexate, Targeted drugs for non-small cell lung

    Not yet recruiting
    • Leptomeningeal Metastasis
    • Recombinant Human Endostatin
    • +2 more
    • (no location specified)
    May 23, 2020

    Leptomeningeal Metastasis, Durvalumab Trial (Durvalumab, methotrexate)

    Not yet recruiting
    • Leptomeningeal Metastasis
    • Durvalumab
    • (no location specified)
    May 22, 2020

    Leptomeningeal Metastasis Trial in Changchun (Pemetrexed, Dexamethasone, Radiotherapy)

    Completed
    • Leptomeningeal Metastasis
    • Changchun, Jilin, China
      The First Hospital of Jilin University
    Dec 23, 2019

    Leptomeningeal Metastasis Trial in Beijing (tomotherapy)

    Completed
    • Leptomeningeal Metastasis
    • tomotherapy
    • Beijing, Beijing, China
      Chinese Academy of Medical Sciences
    Nov 25, 2019

    Leptomeningeal Metastasis, NSCLC, EGFR Activating Mutation Trial (Osimertinib, Bevacizumab)

    Unknown status
    • Leptomeningeal Metastasis
    • +2 more
    • (no location specified)
    Nov 1, 2019